ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
62,565.37
2.25%
S&P 500
5,214.08
0.51%
Dow Jones
39,387.76
0.85%
US Dollar vs Yen
155.498
0.05%
Brent Oil
83.935
0.45%
Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Novelion Therapeutics Inc (NVLN)

  7. Novelion Therapeutics Inc (NVLN) ニュース

NVLN

Novelion Therapeutics (NVLN)

Novelion Therapeutics Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:NVLN
日付受信時刻ニュースソース見出しコード企業名
2020/03/3105 : 30Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:NVLNNovelion Therapeutics Inc
2020/02/1406 : 52Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:NVLNNovelion Therapeutics Inc
2020/01/2207 : 24Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NVLNNovelion Therapeutics Inc
2020/01/2204 : 11Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:NVLNNovelion Therapeutics Inc
2020/01/1607 : 26Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:NVLNNovelion Therapeutics Inc
2020/01/1607 : 12Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:NVLNNovelion Therapeutics Inc
2020/01/1107 : 17Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:NVLNNovelion Therapeutics Inc
2020/01/1020 : 00Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NVLNNovelion Therapeutics Inc
2020/01/0406 : 47Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NVLNNovelion Therapeutics Inc
2019/12/1803 : 38Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:NVLNNovelion Therapeutics Inc
2019/12/1306 : 25Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NVLNNovelion Therapeutics Inc
2019/12/1122 : 28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NVLNNovelion Therapeutics Inc
2019/12/1006 : 52Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NVLNNovelion Therapeutics Inc
2019/11/2707 : 25Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NVLNNovelion Therapeutics Inc
2019/11/2220 : 01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NVLNNovelion Therapeutics Inc
2019/11/1606 : 33Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:NVLNNovelion Therapeutics Inc
2019/11/0604 : 41Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NVLNNovelion Therapeutics Inc
2019/10/1706 : 34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NVLNNovelion Therapeutics Inc
2019/10/0821 : 10GlobeNewswire Inc.Novelion Therapeutics Announces Nasdaq DelistingNASDAQ:NVLNNovelion Therapeutics Inc
2019/10/0821 : 03Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NVLNNovelion Therapeutics Inc
2019/10/0821 : 01Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:NVLNNovelion Therapeutics Inc
2019/10/0419 : 04Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:NVLNNovelion Therapeutics Inc
2019/10/0407 : 21GlobeNewswire Inc.Novelion Therapeutics Announces Filing of Definitive Proxy Statement in Connection with Proposed Liquidation and Other Matter...NASDAQ:NVLNNovelion Therapeutics Inc
2019/10/0406 : 18Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:NVLNNovelion Therapeutics Inc
2019/10/0405 : 42Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NVLNNovelion Therapeutics Inc
2019/10/0405 : 40Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:NVLNNovelion Therapeutics Inc
2019/10/0306 : 15Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:NVLNNovelion Therapeutics Inc
2019/10/0306 : 12Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:NVLNNovelion Therapeutics Inc
2019/09/2806 : 01Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:NVLNNovelion Therapeutics Inc
2019/09/2805 : 59Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NVLNNovelion Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:NVLN

最近閲覧した銘柄

NYSE
VZ
Verizon Communications
CCOM
US100
US Tech 100
FX
USDJPY
US Dollar vs Yen
NASDAQ
TSLA
Tesla
USI
USTECH100
US Tech 100
NYSE
AXP
American Express
USOTC
BASFY
BASF (QX)
NASDAQ
NVDA
NVIDIA
AMEX
XLF
Financial Select Sector
NYSE
NKE
Nike
USOTC
RHHBY
Roche (QX)
NYSE
JPM
JP Morgan Chase
COIN
ETHUSD
Ethereum
NYSE
MCD
McDonalds
NYSE
CVX
Chevron
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有